1.
|
Phase: Phase IV
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: GE-196-001, NCT00785694
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: 2009-03, NCT00868569
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2009-04, NCT00874406
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: NCRI-ACT-II, EU-20056, UKCCCR-ACT-II, ISRCTN26715889, NCT00025090
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 70
Sponsor: Other
Protocol IDs: T1303, NCT00201396
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 69
Sponsor: Other
Protocol IDs: AMC-ONCGI-0102, NCT00296322
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 69
Sponsor: Other
Protocol IDs: AMC-ONCGI-0204, NCT00296335
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: 2008-46, no, NCT00643877
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 102.1, NCT00384891
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCLA-0206060, 02-06-060, NCI-G02-2124, NCT00049322
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3L-03-1, NCT00183885
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: UMCC 2005-060, HUM 00000749, NCT00271011
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: WUCC-0701, NCT00454519
|
|
14.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: GI-24329, NCT00754078
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HZ2-08-01, NCT00782587
|
|
16.
|
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 0034-07-EMC, NCT00491296
|
|
17.
|
Phase: No phase specified
Type: Health services research, Treatment
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: KMUH96-6G24, KMUH96-6G24, NCT00630240
|
|
18.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Pro00003239, NCT00734994
|
